Quantcast

Latest Viral nonstructural proteins Stories

2011-07-28 10:32:00

New tool to help identify areas for increased education and screening for hepatitis C WASHINGTON, July 28, 2011 /PRNewswire-USNewswire/ -- In recognition of World Hepatitis Day, the National Minority Quality Forum today launched the Hepatitis C Index, a novel resource for mapping hepatitis C (http://www.maphepc.com). For the first time, health-care practitioners, policy makers, advocacy groups, and researchers will be able to quantify and map hepatitis C (HCV) prevalence and total...

2011-05-18 12:07:00

ABBOTT PARK, Ill., May 18, 2011 /PRNewswire/ -- Abbott announced today that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR (polymerase chain reaction) test for measuring the viral load of hepatitis C (HCV), the leading cause of liver cancer in the United States. The Abbott RealTime HCV assay, developed for use on the Abbott m2000 system, is intended for use as an aid in the management of HCV-infected patients undergoing antiviral therapy....

2011-04-03 22:03:31

Is this treatment approach the next HCV therapy frontier? Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment (SVR12). In the quadruple therapy study, HCV patients were given four drugs in combination; pegylated Interferon-alpha (PegIFN-alpha);...

2011-01-05 07:00:00

BRISBANE, Calif., Jan. 5, 2011 /PRNewswire/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2011, at 4:30 p.m. EST / 1:30 p.m. PST. To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at...

2010-11-16 12:19:00

In the news release, "The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments, issued Nov. 16, 2010 by Decision Resources over PR Newswire, we are advised by the company that the word "Nearly" in the headline should be replaced by the words "More Than". The complete, corrected release follows: The Hepatitis C Virus Drug Market Will More Than...

2010-04-13 06:30:00

PRINCETON, N.J., April 13 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces the oral presentation of new sustained virologic response (SVR) follow-up data in hepatitis C virus (HCV) genotype 2 and 3 non-responder patients treated for 28 days with RG7128 in combination with the standard of care (SOC), Pegasys® and Copegus®, and presentation of an in vitro combination study with PSI-7977 and PSI-938. Both presentations are at the 45th...

2010-03-29 15:00:00

PRINCETON, N.J., March 29 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the Canaccord Adams Hepatitis C Conference being held Thursday April 1, 2010 at the Peninsula Hotel, New York, NY. Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide a review of the Company's HCV drug pipeline at the conference at 2:00 PM (ET) and Mr. Patrick Higgins, Executive Vice President of Sales and Marketing will be participating...

2010-03-02 08:30:00

WATERTOWN, Mass., March 2 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing. "Our NS5A inhibitor program is well positioned to generate a pipeline of clinical candidates, and we are excited about further...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.